|
Match
|
Document |
Document Title |
|
|
7605134 |
4″-Deoxy-4″-(s)-amino avermectin derivatives
A description is given of compounds of the formula which in the 4″-position has the (S)-configuration and wherein R 1 is C 1 -C 12 alkyl, C 3 -C 8 cycloalkyl; or C 2 -C 12 alkenyl; R 2 is...
|
|
|
7585887 |
Active agent combinations with insecticidal and acaricidal properties
The invention relates to novel active compound combinations having very good insecticidal and acaricidal properties and containing
(a) cyclic ketoenols having the formula
in which the groups...
|
|
|
7582612 |
Multi-action anthelmintic formulations
The present invention provides a method for preparing a pharmaceutical formulation containing ivermectin and a method and composition that can contain ivermectin plus tetrahydropyrimidines. An...
|
|
|
7563773 |
Anthelmintic oral homogeneous veterinary pastes
This invention provides for, inter alia, oral homogeneous veterinary pastes for the treating, controlling and preventing of endo- and ectoparasite infections in warm-blooded animals or birds, such...
|
|
|
7550440 |
Topical application of ivermectin for the treatment of dermatological conditions/afflictions
Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most...
|
|
|
7521429 |
Avermectin B1 monosaccharide derivatives
A compound of formula (I) wherein the bond between carbon atoms 22 and 23 may be a single or a double bond; R 1 is C 1 -C 12 alkyl, C 3 -C 8 cycloalkyl, or C 2 -C 12 alkenyl; R 2 and R 3 are,...
|
|
|
7396820 |
Anthelmintic formulations
The present invention provides a method for preparing a pharmaceutical formulation containing ivermectin and a method and composition that can contain ivermectin plus...
|
|
|
7396819 |
Anthelmintic formulations
The present invention provides a method for preparing a pharmaceutical formulation containing ivermectin and a method and composition that can contain ivermectin plus hexahydropyrazinoisoquinolines...
|
|
|
7378399 |
Avermectins substituted in the 4″ and 4′-positions having pesticidal properties
What is described are a compound of the formula (I) Wherein A-B is —CH═CH— or —CH 2 —CH 2 —; n is 0 or 1; R 1 , is C 1 -C 12 alkyl, C 3 -C 8 cycloalkyl or C 2 -C 12 alkenyl; R 2 and R...
|
|
|
7368435 |
Topical endoparasiticide and ectoparasiticide formulations
A topical formulation having significant parasiticidal activity effective against endoparasites and/or ectoparasites such as heartworms, mites, fleas, ticks, flies is provided, which can be safe to...
|
|
|
7282487 |
Method for treating bacterial infections in horses or pigs with tilmicosin
The invention relates to methods of treating a bacterial infection in a horse or a pig. The method involves administering to the horse or pig a composition comprising (i) a salt made from...
|
|
|
7250402 |
Avermectin derivatives
A compound represented by the general formula (I) or a salt thereof:
wherein
represents —CH═CH—, —CH 2 —CH 2 — or the like,
between R 1 and the carbon atom at 4′-position...
|
|
|
7247617 |
Sixteen-member macrolide antiinfective agents
Sixteen membered macrolide anti-infective agents having a structure according to formula I
where R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined herein, and related compounds are disclosed.
|
|
|
7195773 |
Pesticidal composition
A pesticidal composition comprising a pesticidally effective amount of at least one of a pyridic compound of the formula (I) or it salt and at least one of other pesticides: wherein Y is a...
|
|
|
7144866 |
Avermectin derivatives
Provided is a compound represented by the general formula (I) or a salt thereof:
wherein, —X Y— represents —CH═CH— and the like, between R 2 and the carbon atom at 5-position...
|
|
|
7119076 |
Preventives or remedies for endometriosis or uterine myoma
A drug effective for prevention and therapy of endometriosis and hysteromyoma is disclosed. The drug for prevention and/or therapy of endometriosis and/or hysteromyoma according to the present...
|
|
|
7094431 |
Method of healing skin wounds in mammals and a composition therefor
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or...
|
|
|
7064108 |
Topical ivermectin composition
A topical gel composition comprising between about 0.005 and 1.0% ivermectin, between about 30 and 40% of a pharmaceutically acceptable alcohol, between about 30 and 40% of a pharmaceutically...
|
|
|
7037523 |
Controlled release compositions for macrolide antimicrobial agents
The present invention provides a controlled release pharmaceutical composition of an acid labile, poorly soluble drug having pH dependent solubility profile in aqueous environment. In a preferred...
|
|
|
6998131 |
Spot-on formulations for combating parasites
In particular this invention provides for spot-on compositions for the treatment or prophylaxis of parasite infestations in mammals or birds which comprise:
(1) a composition comprising
...
|
|
|
6991801 |
Topical anthelmintic veterinary formulations
This invention provides for inter alia, topical anthelmintic formulations which comprise a pharmaceutically active combination consisting of at least one macrocyclic compound and at least one...
|
|
|
6962713 |
Spot-on formulations for combating parasites
In particular this invention provides for spot-on compositions for the treatment or prophylaxis of parasite infestations in mammals or birds which comprise:
(1) a composition comprising
...
|
|
|
6919317 |
Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
Synergistic combinations of a squalene epoxidase inhibitor such as terbinafine and a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro, 33-desoxyascomycin are provided,...
|
|
|
6914051 |
Penetrating antibiotic gel for soft tissue diseases
A penetrating antibiotic gel for treating pain, inflammation and other pathological conditions affecting musculoskeletal tissues and other soft tissues of the body. The composition includes an...
|
|
|
6903052 |
Nematicidal compositions and methods
The invention concerns the use of certain compounds related to fatty acids to control nematodes that infest plants or the situs of plants. Nematodes that parasitize animals can also be controlled...
|
|
|
6893652 |
Endoparasiticidal gel composition
A homogenous, clear, veterinary gel composition which has a broad spectrum of efficacy against endoparasites over a prolonged period of time and which allows for higher concentrations of a mixture...
|
|
|
6872708 |
Local injection prescription
A local injection prescription that disperses a malignant tumor to decrease the size of the tumor or terminate the tumor. The local injection prescription is produced by dissolving an organic...
|
|
|
6764999 |
Nasal delivery of parasiticides
A method to treat an animal in need thereof with one or more parasiticides by administering those one or more parasiticides to the nasal pharynx of the animal. A method to increase an animal's...
|
|
|
6746677 |
Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation
The invention relates to certain stable vaccine compositions comprising a macrocyclic lactone compound, a milbemycin compound, an avermectin compound or mixtures thereof; at least one antigen; a...
|
|
|
6710034 |
5-O-mycaminosyltylonide derivatives
There are described novel 5-O-mycaminosyltylonide derivatives and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in...
|
|
|
6680299 |
4'-substituted leucomycins
There are described novel 4′ substituted 16-membered macrolides and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in...
|
|
|
6664240 |
Tylosin derivatives having antibacterial activity
There are described novel substituted tylosin analogs and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a...
|
|
|
6663879 |
Injectable compositions
A stable injectable composition includes a non-aqueous parasitic agent in a therapeutically effect amount, chosen from the group of avermectin, ivermectin, doramectin, abamectin, milbemycin and...
|
|
|
6660718 |
3-modified leucomycin derivatives
A compound represented by the following general formula (I) or a salt thereof: wherein R α represents a C1-C10 alkyl group, a C3-C10 alkenyl group, a C7-C15 aralkyl group, a quinolinylalkyl...
|
|
|
6632443 |
Water-soluble compositions of bioactive lipophilic compounds
Water-soluble compositions comprising a lipophilic compound and a solubilizing agent of the general formula: {X—OOC—[(CH 2 ) n —COO] m } p —Y (I) wherein: X is a residue of a hydrophobic...
|
|
|
6627613 |
Application of water and organic solvent soluble ivermectin for topical and oral use
A stable, palatable solution of Ivermectin in water is provided for the mass medication of animals. The present formulation does not require the use of benzyl alcohol and is stable indefinitely in...
|
|
|
6617314 |
Injectable formulations of avermectins and milbemycins
The present application relates to injection formulations of avermectins and milbemycins based on a solvent mixture comprising sesame oil, medium-chain triglycerides, glycol esters or fatty acid...
|
|
|
6576615 |
4′-O-substituted tylosin analogs
There are described novel 4′ substituted tylosin analogs and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination...
|
|
|
6552002 |
Sustained-release compositions for parenteral administration
Sustained-release compositions comprising a macrolide compound, a surfactant, a co-solvent, and a solvent. The sustained-release compositions of this invention may be parenterally administered to...
|
|
|
6524602 |
Polymer delivery system in treatments for parasitic skin diseases
A formulation for the treatment of a parasitic skin disease includes a parasiticide to kill the parasite. The formulation also includes a polymer effective to increase retention of the formulation...
|
|
|
6514946 |
Macrolide antibiotics and treatment and prophylaxis of pasteurellosis using the same
20,23-disubstituted mycaminosyltylonolide derivatives and use of the same in the field of the prophylaxis and treatment of pasteurellosis are disclosed. The di-substituents are peperidino...
|
|
|
6495591 |
Fungal efflux pump inhibitors
The use of compounds of the milbemycin class as inhibitors of efflux pumps in microbes or other cells is described, along with pharmaceutical compositions incorporating a milbemycin. Also described...
|
|
|
6492340 |
Parasiticidal formulation and a method of making this formulation
A parasiticidal formulation is provided. This formulation includes a pyrrolidone solvent, a bridging solvent, and an parasiticidal agent. One or more parasiticidal agents may be included in the...
|
|
|
6489303 |
Anthelmintic composition
An anthelmintic composition including an Antibiotic S541 compound or a chemical derivative thereof, together with an insoluble anthelmintic compound. The composition is stabilized by between about...
|
|
|
6486128 |
Method of using emamectin to treat fish parasites
A method of eliminating, reducing or preventing parasites in a fish population is provided by feeding emamectin or a salt thereof to the fish population at a daily dose of 25 μg to 400 μg per kg...
|
|
|
6482425 |
Parasiticidal combination
The invention concerns a method and a composition against parasites and particularly ectoparasites and, preferably also endoparasites of small mammals and in particular dogs and cats. The...
|
|
|
6469067 |
Combinations
An active ingredient combination for the simultaneous control of ecto- and endoparasites, especially mites, ticks and nematodes, on productive livestock, domestic animals and pets, is described,...
|
|
|
6462026 |
Bicyclic leucomycins
Bicyclic leucomycins and pharmaceutically acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable...
|
|
|
6461607 |
Probiotic, lactic acid-producing bacteria and uses thereof
The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the...
|
|
|
6416752 |
Termite bait composition and method
An improved termite bait composition comprises a powdered cellulosic attractant having a particle size in the range of approximately 1 to 100 micrometers and a termite killing agent. Also disclosed...
|